New study finds everolimus benefits high-risk kidney cancer patients
A potential treatment for the world’s leading cause of kidney failure in children needing dialysis has been discovered by an international team of scientists. The University of Bristol-led breakthrough is published today [19 October] in Med.
A team of European researchers has developed a new test that can accurately measure biological aging in a clinical setting. The discovery was made while studying patients for the aging effects of chronic kidney disease.
Los hispanos y latinos con enfermedad renal crónica corren un riesgo significativo de sufrir un paro cardíaco repentino, de acuerdo a un nuevo estudio del Smidt Heart Institute en Cedars-Sinai.
Hispanics and Latinos with chronic kidney disease are at significant risk for suffering from sudden cardiac arrest, according to a new study from the Smidt Heart Institute at Cedars-Sinai.
Research Highlights: Chronic kidney disease was strongly associated with an increased risk of sudden cardiac arrest among Hispanic/Latino adults, in a new study. Early identification and management of kidney disease may reduce risk of sudden cardiac arrest among Hispanic/Latino people, researchers suggest.
Improving insulin resistance with metformin, a medication used to treat Type 2 diabetes, reduced the chances of developing kidney disease in a prepubescent obese rat model, according to a new study from the University of Mississippi Medical Center.
Dr. Seo, Moon-Hyeong of the Natural Product Research Center at the Korea Institute of Science and Technology (KIST), together with Dr. Park, Keunwan of the Natural Product Informatics Research Center, have developed a technology that can quickly and accurately measure glutamine concentrations without complicated measurement processes and expensive analytical equipment through the principle of 'ligand-induced protein assembly'.
Health experts are redefining cardiovascular disease (CVD) risk, prevention and management, according to a new American Heart Association presidential advisory published today in the Association’s flagship journal Circulation.
African Americans have long been known to be at increased risk of kidney disease due to a dangerous genetic mutation that creates a hole in the kidney cells, but Vanderbilt University Medical Center (VUMC) researchers have now discovered a protective genetic mutation that covers the hole to eliminate the risk.
Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted, high-dose radiation, a new study from Australian and Dutch researchers suggests.
Below are some of the latest headlines in the Women's Health channel on Newswise.
The genetic code of a rare form of kidney cancer, called reninoma, has been studied for the first time.
The American Society of Nephrology (ASN) congratulates the House and Senate sponsors of the Securing the U.S. Organ Procurement and Transplantation Network (OPTN) Act upon President Biden signing the legislation and thanks the Biden-Harris administration for its commitment to improving American’s access to transplantation.
Funded by NIH, the five-year study builds off a pilot study that pointed to an association between changes in the gut microbiome and pain that interferes with a person’s daily activities, a symptom that nearly half of kidney transplant patients experience.
Successful kidney transplants rely on the biological compatibility of the donor and recipient but still require long-term use of drugs to tamp down the recipient’s immune system and prevent donor organ rejection.
American Society of Nephrology publications contribute to the improved kidney health of more than 850,000,000 people worldwide and 37,000,000 Americans affected by kidney diseases.
The August 2023 issue of SLAS Technology, the open access journal emphasizing scientific and technical advances across the life sciences, is now available.
A nephrologist explains the damage that this trend can cause
A new study from clinicians and researchers at the University of Michigan Rogel Cancer Center, U-M Department of Pathology and the Michigan Center for Translational Pathology reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.
Researchers at the University of Bristol have made a remarkable step forward in finding a potential cure for a type of childhood kidney disease.
The Radiological Society of North America (RSNA) has launched the “RSNA 2023 Abdominal Trauma Detection AI Challenge” to explore whether artificial intelligence (AI) can be used to aid in the detection and classification of traumatic abdominal injuries.
In an observational study, researchers showed that consuming more added sugars is consistently associated with greater odds of developing kidney stones in the US, especially for ethnicities such as Native Americans or Asians, or for people with a relatively higher income. The mechanisms of this relationship, and whether it is directly causal, aren’t yet known.
rancis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney and bladder cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its Vanquish minimally invasive water vapor ablation therapy.
20240208171546.png&width=400&height=400)
Memorial Sloan Kettering Cancer Center has been recognized as the best cancer center in the northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by U.S. News & World Report in its annual Best Hospitals listing.
Hyung L. Kim, MD, a leading urologic oncologist, skilled surgeon and accomplished researcher frequently funded by the National Institutes of Health, was recently selected to be the inaugural chair of the Department of Urology at Cedars-Sinai.
The United States Senate unanimously passed the Securing the U.S. Organ Procurement Transplantation Network (OPTN) Act (S. 1668), following House passage earlier this week, marking a new era for the United States transplant system.
According to the National Kidney Foundation, more than 100,000 Americans are waiting for a kidney transplant, and the demand for donated kidneys far exceeds the supply. In fact, only 25,498 kidney transplants were performed in 2022, and kidney disease impacts 37 million people in the U.S. But a new preclinical study, led by scientists at Wake Forest University School of Medicine, shows that a new technology called mitochondrial transplantation holds promise as a potential therapy that could change the kidney transplant landscape.
The American Society of Nephrology (ASN) celebrates the unanimous passage of the Securing the U.S. Organ Procurement Transplantation Network (OPTN) Act (H.R. 2544) by the United States House of Representatives. This bipartisan legislation will increase transparency, accountability, and competition in the U.S. transplant system.
The Hypertension Center in the Smidt Heart Institute at Cedars-Sinai has earned accreditation from the American Heart Association, signifying that it exceeds the highest standards of care for patients with high blood pressure—a condition that affects nearly half of all U.S. adults and increases risk for heart attack, stroke and kidney failure.
Valance Sams Sr.’s world was turned upside down 10 years ago when he was diagnosed with sarcoidosis, a rare inflammatory disease that caused a buildup of scar tissue on his heart and left him unable to work, exercise or even walk.
Based on findings from a study published today in the journal, The Lancet Regional Health – Americas, researchers at Johns Hopkins Medicine and three collaborating medical institutions suggest that people living with the human immunodeficiency virus (HIV) who donate a kidney to other people living with HIV (PLWH) have a low risk of developing end-stage kidney disease (ESKD) or other kidney problems in the years following the donation.
Long-term circadian disruption in a rat model of high blood pressure accelerated stroke onset and shortened lifespan, according to researchers from Morehouse School of Medicine in Atlanta.
Researchers find indicators while studying hundreds of donor samples
In the next step toward producing the answer to kidney transplantation shortages, Dr. Anthony Atala, Director of the Wake Forest Institute for Regenerative Medicine (WFIRM), and the kidney research team, have been awarded the prestigious KidneyX Track 2 $1 Million Prize for work based on a 3D kidney construct platform.
Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney, and bladder cancer, today announced the first patient has been treated in the company's VAPOR 2 pivotal clinical study evaluating the safety and efficacy of its Vanquish minimally invasive water vapor ablation therapy for managing prostate cancer.
Ochsner Health announced today that it has become the first healthcare organization in Louisiana to offer Aquablation therapy for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (BPH).
Approximately 90,000 Americans, including 1,100 children are currently waiting for a kidney transplant. Tragically, 12 Americans will die today waiting for a kidney. Advocates from the American Society of Nephrology (ASN) are on Capitol Hill today urging Congress to implement reforms that will help maximize access to transplant care for the 37 million Americans living with kidney diseases; the 8th leading cause of death in the United States.
Urotronic, Inc., a Minnesota-based medical device company pioneering the application of its drug-coated balloon technologies for use in interventional urology, today announced the world's first commercial procedure of the Optilume BPH® Catheter System to treat benign prostatic hyperplasia (BPH) was completed by Dr. Dean Elterman, urologist at University Urology Associates, in Toronto, Canada.
Fiscal year 2023, which ended June 30, proved to be the busiest year yet for Cedars-Sinai’s Comprehensive Transplant Center and Smidt Heart Institute, with more than 600 organs transplanted.
Artificial intelligence is becoming increasingly important in drug discovery.
Patients who engage in light exercise while undergoing dialysis are physically fitter and are admitted to hospital less frequently than those who do not.
Researchers at the UCLA Jonsson Comprehensive Cancer Center have confirmed that a large number of genetic variants of unknown significance are in fact verified mutations that predispose patients to a rare hereditary syndrome that increases the risk of kidney cancer.
When an ill person schedules a doctor visit, blood work or other diagnostic testing is often required before a diagnosis is determined. Missouri University of Science and Technology electrical engineering researcher Dr. Jie Huang is developing technology that would allow patients to “just breathe” and avoid that testing.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
